Rituximab in Membranous Nephropathy: Is It a First-Line Treatment?

被引：8
|
作者：
Appel, Gerald B. [1 ]
机构：
[1] Columbia Univ, Med Ctr, Columbia Univ Coll Phys & Surg, Dept Med,Div Nephrol, New York, NY 10032 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 23卷 / 08期
关键词：
THERAPY; ANTIGEN;
D O I：
10.1681/ASN.2012060602
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1282
页数：3
相关论文
共 50 条
  • [21] Overcoming Calcineurin Dependence in Membranous Nephropathy: Is Rituximab the Answer?
    Fervenza, Fernando C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (06): : 1017 - 1019
  • [22] Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
    Hu, Xiaofan
    Zhang, Muyin
    Xu, Jing
    Gao, Chenni
    Yu, Xialian
    Li, Xiao
    Ren, Hong
    Wang, Weiming
    Xie, Jingyuan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (12): : 1594 - 1602
  • [23] Is rituximab suitable for use as a first-line biologic therapy for RA?
    Kleiner, Anatole
    Looney, R. John
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 574 - 575
  • [24] Rituximab as first-line treatment for the management of adult patients with non-severe hemophiliaA and inhibitors
    Lim, M. Y.
    Nielsen, B.
    Lee, K.
    Kasthuri, R. S.
    Key, N. S.
    Ma, A. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (06) : 897 - 901
  • [25] Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma
    Okamura, Ikue
    Imai, Hisao
    Mori, Keita
    Ogura, Kazuto
    Isoda, Atsushi
    Mihara, Keichiro
    Matsumoto, Morio
    Saito, Ryusei
    Takahashi, Toshiaki
    Ikeda, Takashi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (01) : 46 - 51
  • [26] Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
    Teisseyre, Maxime
    Allinovi, Marco
    Audard, Vincent
    Cremoni, Marion
    Belvederi, Giulia
    Karame, Alexandre
    Accinno, Matteo
    Duquesne, Julien
    Sharma, Vinod
    Fernandez, Celine
    Zorzi, Kevin
    El Mai, Mounir
    Brglez, Vesna
    Benzaken, Sylvia
    Esnault, Vincent L. M.
    Vultaggio, Alessandra
    Kohli, Harbir Singh
    Ramachandran, Raja
    Cirami, Calogero Lino
    Seitz-Polski, Barbara
    KIDNEY INTERNATIONAL REPORTS, 2025, 10 (03): : 753 - 761
  • [27] Efficacy and safety of rituximab in the treatment of membranous nephropathy A systematic review and meta-analysis
    Lu, WanJun
    Gong, ShuHao
    Li, Juan
    Luo, HongWen
    Wang, Ying
    MEDICINE, 2020, 99 (16) : E19804
  • [28] First-line Treatment of Pemphigus Vulgaris With a Combination of Rituximab and High-Potency Topical Corticosteroids
    Ingen-Housz-Oro, Saskia
    Valeyrie-Allanore, Laurence
    Cosnes, Anne
    Ortonne, Nicolas
    Huee, Sophie
    Paul, Muriel
    Wolkenstein, Pierre
    Chosidow, Olivier
    JAMA DERMATOLOGY, 2015, 151 (02) : 200 - 203
  • [29] Strategies for First-Line Treatment of mCRPC
    Miller, K.
    Gschwend, J.
    Wolff, J. -M.
    AKTUELLE UROLOGIE, 2016, 47 (05) : 395 - 401
  • [30] Membranous nephropathy treatment standard
    Radhakrishnan, Yeshwanter
    Zand, Ladan
    Sethi, Sanjeev
    Fervenza, Fernando C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (03) : 403 - 413
12345